Description
COST PER REPORTABLE RESULTS TESTS
First action · last action
2009-09-11 · 2009-09-11
Transactions
1
First transaction's obligation
$595,200
Base + all options value (sum of deltas)
$595,200
Extent competed
NON-COMPETITIVE DELIVERY ORDER
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
—
SDVOSB flag on record
No
Parent IDV
V797P7136A
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2009-09-11+$595,200= $595,200
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2009-09-11 | +$595,200 | $595,200 | COST PER REPORTABLE RESULTS TESTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI STNDUK44ENE8)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26226N0941 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $25,596 | FY2026 |
| 36C24726N0361 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · Q403 · MEDICAL- EVALUATION/SCREENING | $90,000 | FY2026 |
| 36C25726N0497 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $30,770 | FY2026 |
| 36C24526N0729 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $90,000 | FY2026 |
| 36C24526A0052 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $0 | FY2026 |
| 36C25726N0398 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $68,049 | FY2026 |
Other recipients under 6505 from 262-NETWORK CONTRACT OFFICE 22 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26216J3405 | SANOFI VACCINES US INC. | 262-NETWORK CONTRACT OFFICE 22 | $209,679 | FY2016 |
| VA26216P3483 | JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC. | 262-NETWORK CONTRACT OFFICE 22 | $14,960 | FY2016 |
| VA26216E3967 | MCKESSON CORPORATION | 262-NETWORK CONTRACT OFFICE 22 | $20,913,958 | FY2016 |
| VA26216P2987 | PETNET SOLUTIONS, INC. | 262-NETWORK CONTRACT OFFICE 22 | $58,136 | FY2016 |
| VA26216E3446 | MCKESSON CORPORATION | 262-NETWORK CONTRACT OFFICE 22 | $11,612,703 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA691C90108_3600_V797P7136A_3600 · retrieved 2026-09-26.